Complete remission in a patient with metastatic gastric cancer receiving tislelizumab combined with chemotherapy: a case report

The prognosis for patients with advanced gastric cancer (AGC) is poor, with limited treatment options available due to the difficulty of resection. In recent years, chemotherapy and immunotherapy for AGC have shown promising efficacy. However, there is a controversy regarding the surgery of primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhe, Dai, Pei-Lin, Han, Shuai, Qiu, Enming, Wang, Yu, Li, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206281/
https://www.ncbi.nlm.nih.gov/pubmed/37234987
http://dx.doi.org/10.3389/fonc.2023.1147636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206281/
https://www.ncbi.nlm.nih.gov/pubmed/37234987
http://dx.doi.org/10.3389/fonc.2023.1147636

Ejemplares similares